Disorders Due to Cocaine Use (ICD-11: 6C45)

1. Introduction

Disorders due to cocaine use represent a fundamental diagnostic category in the international classification of diseases, encompassing a spectrum of clinical conditions resulting from the consumption of this psychoactive substance. Cocaine, extracted from the leaves of the plant Erythroxylum coca, native to the Andean region of South America, has become one of the most consumed illicit substances globally, generating significant challenges for health systems across all continents.

As a potent stimulant of the central nervous system, cocaine produces intense effects of euphoria, increased energy, and hyperactivity, characteristics that contribute to its high potential for dependence. The substance is found mainly in two forms: cocaine hydrochloride (white crystalline powder) and cocaine freebase, popularly known as crack, each with distinct profiles of use and clinical consequences.

The clinical importance of cocaine-related disorders is amplified by their increasing prevalence in diverse social contexts and by the severity of medical, psychiatric, and social complications associated with them. Health professionals regularly encounter clinical presentations related to cocaine use, ranging from acute intoxications in emergency services to chronic dependence presentations in specialized outpatient clinics.

Precise coding using the code 6C45 from ICD-11 is critical for multiple purposes: it enables appropriate epidemiological tracking, facilitates proper allocation of health resources, ensures correct reimbursement of procedures, enables international comparative research, and grounds public policies based on evidence. Adequate documentation of these disorders is essential for continuity of care and for understanding the magnitude of this global public health problem.

2. Correct ICD-11 Code

Code: 6C45

Description: Disorders due to cocaine use

Parent category: Disorders due to substance use

Official definition: Disorders due to cocaine use are characterized by the pattern and consequences of use of this substance. Cocaine is an alkaloid compound found in the leaves of the coca plant, Erythroxylum coca, which has limited medical use as a local anesthetic agent and vasoconstrictor. However, it is commonly used illicitly and is widely available around the world.

The substance presents itself mainly in two chemical forms: cocaine hydrochloride, generally inhaled or injected, and cocaine free base (crack), typically smoked. As a central nervous system stimulant, cocaine acts by blocking the reuptake of monoaminergic neurotransmitters, particularly dopamine, norepinephrine, and serotonin, producing characteristic effects.

Cocaine intoxication typically includes a state of intense euphoria, hyperactivity, increased energy and alertness, decreased need for sleep, and sensation of increased confidence. Cocaine possesses potent dependence-generating properties, with rapid development of tolerance and compulsive patterns of use. Cocaine dependence is a common cause of significant morbidity and represents one of the most frequent clinical presentations in specialized services for substance-related disorders.

Cocaine withdrawal syndrome presents a characteristic course that includes pronounced lethargy, depressed mood, anhedonia, irritability, increased appetite, and sleep disturbances. A broad range of cocaine-induced mental disorders is also described within this category, including psychotic, mood, and anxiety disorders.

3. When to Use This Code

The code 6C45 should be applied in specific clinical situations where cocaine use results in problematic patterns or adverse consequences. Here are detailed practical scenarios:

Scenario 1: Established Cocaine Dependence A patient presents to outpatient consultation reporting daily cocaine use via nasal inhalation for 18 months. He describes a need for progressively larger doses to obtain the same effects (tolerance), repeated and unsuccessful attempts to stop use, abandonment of professional and social activities due to consumption, and withdrawal symptoms (extreme fatigue, depression, irritability) when attempting to stop. Code 6C45 is appropriate when there is clear evidence of a dependence pattern with loss of control over use.

Scenario 2: Acute Cocaine Intoxication with Complications An individual is brought to the emergency department presenting with intense psychomotor agitation, tachycardia (heart rate of 140 bpm), severe hypertension, mydriasis, profuse diaphoresis, and aggressive behavior following crack use. The patient confirms recent substance use. This code is indicated to document acute cocaine intoxication, especially when there is a need for medical intervention.

Scenario 3: Cocaine Withdrawal Syndrome A patient hospitalized for another reason who was a regular cocaine user develops on the second day of hospitalization symptoms of profound lethargy, significantly depressed mood, marked anhedonia, hypersomnia, and marked increase in appetite. There is no access to the substance in the hospital environment. Code 6C45 appropriately documents this characteristic withdrawal syndrome.

Scenario 4: Cocaine-Induced Psychotic Disorder A chronic cocaine user develops psychotic symptoms including paranoid delusions, tactile hallucinations (sensation of insects under the skin - "formication"), and bizarre behavior during a period of intensive use. The symptoms are clearly temporally related to substance use and are not better explained by another primary psychotic disorder. Code 6C45 is appropriate to capture this cocaine-induced mental disorder.

Scenario 5: Harmful Cocaine Use with Health Damage A patient presents with nasal septum perforation, significant weight loss, neglect of personal care, and functional deterioration directly attributable to regular cocaine use via inhalation. There is clear evidence of physical and psychological damage caused by the substance, but the pattern may not meet all criteria for dependence. Code 6C45 is still applicable to document harmful use.

Scenario 6: Episodic Pattern with Severe Consequences A professional presents with episodic cocaine use ("binge"), with periods of intensive consumption followed by intervals of abstinence. During use episodes, there is significant impairment of judgment, risky behaviors, neglect of responsibilities, and interpersonal problems. Code 6C45 is appropriate even for non-continuous patterns when there are significant adverse consequences.

4. When NOT to Use This Code

It is essential to distinguish situations where code 6C45 is not appropriate to ensure diagnostic accuracy:

Exclusion 1: Disorders Due to Other Stimulants If the patient presents with disorders related to the use of amphetamines, methamphetamine, methcathinone, or other synthetic stimulants, the correct code is 1016273204 (Disorders due to use of stimulants, including amphetamines, methamphetamine, or methcathinone). Although these substances share stimulant properties with cocaine, they possess distinct pharmacological profiles, different durations of action, and specific use patterns that justify separate coding.

Exclusion 2: Hazardous Use of Cocaine Without Established Disorder When there is evidence of hazardous use of cocaine (pattern of use that significantly increases the risk of harmful consequences), but there has not yet been development of dependence, withdrawal, or other induced mental disorders, the appropriate code is 1385385359 (Hazardous use of cocaine). This code captures risk situations without the presence of an established disorder.

Exclusion 3: Single Intoxication Without Problematic Pattern An isolated episode of recreational cocaine use without a history of problematic use, dependence, or significant adverse consequences does not justify code 6C45. Coding should reflect established disorders, not occasional experimentation.

Exclusion 4: Primary Unrelated Mental Disorders If a patient has a primary psychotic, mood, or anxiety disorder that exists independently of cocaine use, and substance use is secondary or incidental, the primary code should reflect the underlying mental disorder. Code 6C45 is only appropriate when the mental disorder is clearly induced or substantially exacerbated by cocaine.

Exclusion 5: Isolated Medical Complications Medical complications of cocaine use (such as myocardial infarction, cerebrovascular accident, or septal perforation) should be coded with their specific codes. Code 6C45 may be used as an additional diagnosis to contextualize the etiology, but does not replace coding of the specific medical condition.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

Confirmation of diagnosis requires systematic and comprehensive evaluation. Begin with a detailed clinical history exploring the pattern of cocaine use: frequency, amount, route of administration (inhalation, injection, smoking), duration of use, and progression over time. Investigate previous attempts to cease or control use and their outcomes.

Assess specific dependence criteria: development of tolerance (need for increasing amounts), withdrawal symptoms upon cessation of use, use in larger amounts or for longer periods than intended, persistent desire or unsuccessful efforts to control use, excessive time spent in activities related to obtaining and using the substance, abandonment of important activities, and continued use despite adverse consequences.

Utilize standardized assessment instruments when available, such as ASSIST (Alcohol, Smoking and Substance Involvement Screening Test) for initial screening, or more detailed assessments for dependence. Physical examination should seek signs of chronic use: perforation or inflammation of the nasal septum, injection marks, weight loss, cardiovascular signs. Consider laboratory tests including urine toxicology for objective confirmation.

Step 2: Verify Specifiers

ICD-11 allows additional specification of cocaine-related disorders. Determine whether there is a current (active) use pattern or remission. For dependence, assess severity based on the number of criteria met and the degree of functional impairment.

Identify whether there is a current episode of intoxication or withdrawal, documenting specific symptoms present. If there is a cocaine-induced mental disorder (psychotic, mood, anxiety), specify the type and temporal relationship with substance use.

Document the predominant route of administration, as this has prognostic and therapeutic implications. Crack users, for example, frequently present with more intense use patterns and greater severity of dependence compared to users who inhale.

Step 3: Differentiate from Other Codes

6C40: Disorders due to use of alcohol The fundamental differentiation lies in the substance used. While alcohol is a central nervous system depressant producing sedation, disinhibition, and motor impairment, cocaine is a stimulant causing euphoria, hyperactivity, and increased energy. Intoxication patterns are opposite: alcohol causes lethargy and incoordination; cocaine causes agitation and hyperactivity. However, concurrent use is common and both codes may be applied when appropriate.

6C41: Disorders due to use of cannabis Cannabis produces distinct psychoactive effects including relaxation, perceptual alterations, increased appetite, and mild sedation, contrasting with the stimulant effects of cocaine. Cannabis withdrawal syndrome is more subtle and less intense. Cannabis has lower potential for physical dependence compared to cocaine. Differentiation is generally clear from use history and clinical presentation.

6C42: Disorders due to use of synthetic cannabinoids Although these are different substances, differentiation is based on the specific substance used. Synthetic cannabinoids produce effects similar to cannabis but frequently more intense and unpredictable. Use history should clarify which substance is being consumed. Toxicological analyses may be necessary for definitive distinction in ambiguous cases.

Step 4: Necessary Documentation

Adequate documentation should include:

Checklist of Mandatory Information:

• Specific substance used (powder cocaine, crack)
• Predominant route of administration
• Use pattern (frequency, amount, duration)
• Specific diagnostic criteria met
• Presence or absence of tolerance and withdrawal
• Documented adverse consequences (medical, psychological, social, occupational)
• Previous treatment attempts and their outcomes
• Medical and psychiatric comorbidities
• Concurrent use of other substances
• Current status (active use, early remission, sustained remission)

Adequate Recording: Documentation should be objective, specific, and evidence-based. Use direct patient quotations when relevant. Document behavioral observations and physical examination findings. Record results of laboratory and toxicological tests. Include detailed functional assessment documenting impact on important life areas.

6. Complete Practical Example

Clinical Case

Initial Presentation: A 32-year-old male patient presents to the mental health outpatient clinic referred by his family physician due to concerns about substance use and functional deterioration. He reports intranasal cocaine use initiated approximately four years ago, which has progressively intensified. Currently, he uses cocaine 5-6 days per week, consuming approximately 2-3 grams on each occasion of use.

The patient describes that he initially used cocaine only in social contexts on weekends, but gradually the use became more frequent and solitary. Over the past 12 months, he has made seven attempts to discontinue use on his own, all unsuccessful, with relapses occurring within 3-5 days. He reports that when he attempts to stop, he experiences extreme fatigue, intense depressed mood, marked irritability, and significant increase in appetite, symptoms that lead him to resume use for relief.

Evaluation Performed: During the structured clinical interview, the patient admits that he requires progressively larger amounts of cocaine to obtain the desired effects (tolerance). He spends approximately 4-5 hours daily in activities related to obtaining and using the substance. He has abandoned previously valued hobbies and significantly reduced social contacts. His work performance has deteriorated with multiple absences and warnings at work.

Physical examination reveals nasal septal perforation, weight loss of approximately 8 kg over the past six months, and signs of self-care neglect. Blood pressure is elevated (150/95 mmHg) and heart rate is 98 bpm at rest. Mental status examination shows moderate anxiety, slightly depressed mood, but without current psychotic symptoms. Urine toxicology test is positive for cocaine metabolites.

Additional evaluation reveals no preexisting primary psychiatric disorders. The patient denies significant use of other substances except occasional alcohol consumption (2-3 drinks per week). There is no significant family history of substance-related disorders.

Diagnostic Reasoning: The patient meets multiple criteria for cocaine dependence: use in larger amounts and for longer periods than intended, persistent desire and unsuccessful efforts to control use, excessive time spent in substance-related activities, abandonment of important activities, development of tolerance, and characteristic withdrawal syndrome. There is clear evidence of significant functional impairment in multiple life areas.

The septal perforation and weight loss document direct physical harm. Work deterioration and social isolation demonstrate significant adverse consequences. The progression of the use pattern from occasional recreational use to compulsive daily use illustrates the nature of dependence.

There is no evidence of primary mental disorder that better explains the presentation. Depressive and anxious symptoms appear secondary to cocaine use and withdrawal syndrome, not constituting independent disorders.

Coding Justification: The code 6C45 (Disorders due to cocaine use) is the appropriate primary code. This code adequately captures established cocaine dependence with multiple adverse consequences. The severity is moderate to severe based on the number of criteria met and the degree of functional impairment.

Step-by-Step Coding:

1. Substance confirmation: Cocaine (hydrochloride) confirmed by history and toxicology
2. Criteria verification: Multiple dependence criteria met
3. Exclusion of alternatives: No problematic use of other synthetic stimulants; it is not merely "hazardous use" as established dependence is present
4. Primary code: 6C45 - Disorders due to cocaine use
5. Complementary codes: Consider additional code for hypertension (if it persists after evaluation) and for specific physical complications (septal perforation)

7. Related Codes and Differentiation

Within the Same Category

6C40: Disorders due to use of alcohol When to use vs. 6C45: Use 6C40 when alcohol is the primary substance causing dependence, intoxication, withdrawal, or substance-induced mental disorders. Alcohol is a central nervous system depressant with a profile of effects completely different from cocaine.

Main difference: Alcohol causes sedation, disinhibition, motor and cognitive impairment, while cocaine causes stimulation, euphoria, and hyperactivity. Alcohol withdrawal can be medically dangerous with risk of seizures and delirium tremens, while cocaine withdrawal, although uncomfortable, is rarely medically dangerous. Both codes can coexist when there is problematic use of both substances.

6C41: Disorders due to use of cannabis When to use vs. 6C45: Apply 6C41 when cannabis (marijuana, hashish) is the substance causing dependence or other disorders. Cannabis has unique psychoactive effects including relaxation, perceptual alterations, and increased appetite.

Main difference: Cannabis is not a stimulant and produces relaxing/sedative effects contrasting with the stimulant effects of cocaine. The dependence potential of cannabis is generally lower than that of cocaine. Cannabis withdrawal syndrome is more subtle. Differentiation is clear by the substance used, although concurrent use is common.

6C42: Disorders due to use of synthetic cannabinoids When to use vs. 6C45: Use 6C42 for disorders related to synthetic cannabinoids (chemical substances that mimic cannabis effects). These are completely different substances from cocaine.

Main difference: Synthetic cannabinoids produce effects similar to cannabis but often more intense. They are different substances with mechanisms of action distinct from cocaine. The history of use should clarify which substance is being consumed.

Differential Diagnoses

Bipolar Disorder or Attention-Deficit/Hyperactivity Disorder: Can be confused with cocaine intoxication due to hyperactivity and euphoria. Differentiation requires careful longitudinal history, identifying whether symptoms exist independently of substance use and whether there is objective evidence of cocaine use.

Primary Psychotic Disorders: Psychotic symptoms induced by cocaine (particularly paranoia and tactile hallucinations) can mimic schizophrenia. The temporal relationship with substance use, resolution of symptoms with abstinence, and absence of symptoms during prolonged periods without use help distinguish them.

Anxiety Disorders: Anxiety can be a symptom of cocaine intoxication or withdrawal, or it can be a primary disorder. Timeline is fundamental: symptoms that precede cocaine use or persist during prolonged abstinence suggest a primary disorder.

8. Differences with ICD-10

In ICD-10, cocaine-related disorders were coded under category F14 (Mental and behavioral disorders due to cocaine use), with subdivisions based on the specific type of presentation (F14.0 for acute intoxication, F14.1 for harmful use, F14.2 for dependence syndrome, etc.).

Main changes in ICD-11: ICD-11 adopts a more integrated and clinically oriented approach. Code 6C45 functions as the main category, with additional specifiers allowing detailed characterization of the specific type of disorder (dependence, intoxication, withdrawal, substance-induced mental disorders) without the need for completely separate codes.

ICD-11 offers greater flexibility in coding comorbidities and multiple substance use, recognizing that polysubstance use patterns are common. The terminology has been updated to better reflect contemporary understanding of substance-related disorders, with emphasis on use patterns and functional consequences.

The distinction between "harmful use" and "dependence" has been refined in ICD-11, with clearer and more clinically applicable criteria. The category also better integrates substance-induced mental disorders, recognizing that these are part of the spectrum of cocaine-related disorders.

Practical impact: The transition to ICD-11 requires familiarity with the new coding structure. Electronic medical record systems need to be updated. Professionals must be trained in the application of new criteria. Comparability with historical data coded in ICD-10 requires appropriate conversion tables. However, ICD-11 offers greater diagnostic precision and better alignment with contemporary clinical practice.

9. Frequently Asked Questions

How is the diagnosis of disorders due to cocaine use made? The diagnosis is primarily clinical, based on detailed history and physical examination. The interview should explore patterns of use, adverse consequences, attempts to cease use, and symptoms of dependence. Standardized screening instruments can assist in systematic evaluation. Toxicological tests (urine, blood) confirm recent use but do not establish a diagnosis of dependence by themselves. The diagnosis requires evidence of a problematic pattern of use with significant adverse consequences or loss of control. Evaluation of medical and psychiatric comorbidities is essential for appropriate therapeutic planning.

Is treatment available in public health systems? The availability of treatment for cocaine-related disorders varies considerably among different health systems. Many public systems offer some level of treatment, typically including initial evaluation, counseling, psychosocial therapies, and management of medical complications. Specialized services in substance dependence, when available, offer more intensive approaches including structured outpatient programs, hospitalization for detoxification when necessary, and long-term follow-up. Coverage and accessibility vary, but there is growing recognition of the need to treat substance-related disorders as legitimate medical conditions requiring professional intervention.

How long does treatment last? The duration of treatment varies significantly based on the severity of dependence, presence of comorbidities, individual response to treatment, and available resources. Intensive outpatient programs typically last 8-12 weeks, but long-term follow-up is often necessary. Cocaine dependence is a chronic and recurrent condition, and many patients benefit from continued support for months or years. There is no "standard" duration—treatment should be individualized and continue as long as there is clinical benefit. Relapses are common and do not represent treatment failure, but indicate the need for adjustment in the therapeutic approach.

Can this code be used in medical certificates? Yes, code 6C45 can be used in official medical documentation including certificates, when clinically appropriate and necessary. However, considerations of confidentiality and stigma should be weighed. In some situations, it may be appropriate to use more general terminology in documents that will be widely shared, while maintaining detailed documentation in protected medical records. The decision should balance the need for accurate documentation for continuity of care and reimbursement with protection of patient privacy and minimization of potential discrimination. Specific legislation regarding privacy of information related to substance use disorders should be observed.

What are the main medical complications of cocaine use? The medical complications are extensive and potentially severe. Cardiovascular: myocardial infarction, arrhythmias, cardiomyopathy, hypertension, aortic dissection. Neurological: stroke, seizures, headache. Respiratory (especially with crack): pneumothorax, alveolar hemorrhage, asthma exacerbation. Otolaryngological: nasal septum perforation, chronic sinusitis, loss of smell. Psychiatric: psychosis, depression, anxiety, suicidal ideation. Other: weight loss, malnutrition, sexual dysfunction, infectious complications (when injected). Early identification and management of these complications are essential components of care.

Can cocaine dependence be treated with medications? Currently, there are no medications specifically approved for the treatment of cocaine dependence, unlike other substances such as opioids or alcohol. Research is ongoing exploring various pharmacological options. In current clinical practice, medications are used to treat psychiatric comorbidities (depression, anxiety, attention deficit disorder) and specific symptoms. Some medications have preliminary evidence of benefit in reducing cocaine use, but none have demonstrated sufficient consistent efficacy for regulatory approval. Treatment is based primarily on psychosocial interventions, including cognitive-behavioral therapy, contingency management, and support groups.

Does occasional cocaine use always result in dependence? No. Although cocaine has high dependence potential, not all users develop dependence. Multiple factors influence risk including genetics, frequency and amount of use, route of administration (crack has higher risk than inhalation), age of onset, presence of coexisting mental disorders, and environmental factors. Occasional use still presents significant risks of acute medical complications (cardiovascular events, overdose) and adverse consequences (risky behaviors, legal problems). Progression from recreational use to dependence can occur rapidly in vulnerable individuals. Primary prevention and early intervention are fundamental.

How to differentiate cocaine withdrawal symptoms from primary depression? Differentiation can be challenging, as both present with depressed mood, anhedonia, fatigue, and sleep alterations. Key factors for distinction: (1) Chronology—withdrawal symptoms begin within hours to days after cessation of use and typically improve within 1-2 weeks; primary depression has a course independent of substance use. (2) Specific symptoms—cocaine withdrawal characteristically includes hypersomnia and increased appetite; depression may present with insomnia and loss of appetite. (3) Prior history—depressive symptoms that precede cocaine use or persist during prolonged periods of abstinence suggest a primary disorder. (4) Treatment response—withdrawal symptoms resolve spontaneously with time; primary depression requires specific treatment. Careful longitudinal evaluation is often necessary for definitive distinction.

---

Conclusion: The ICD-11 code 6C45 for disorders due to cocaine use is an essential diagnostic tool for healthcare professionals globally. The accurate application of this code requires detailed understanding of cocaine use patterns, clinical manifestations of dependence, intoxication and withdrawal, and careful differentiation of other substance-related disorders. Appropriate documentation not only facilitates appropriate individual care, but also contributes to epidemiological understanding of this significant public health condition. With adequate training and attention to diagnostic criteria, professionals can use this code effectively to improve patient outcomes and inform evidence-based health policies.

External References

This article was prepared based on reliable scientific sources:

1. 🌍 WHO ICD-11 - Disorders due to cocaine use
2. 🔬 PubMed Research on Disorders due to cocaine use
3. 🌍 WHO Health Topics
4. 📋 NICE Mental Health Guidelines
5. 📊 Clinical Evidence: Disorders due to cocaine use
6. 📋 Ministry of Health - Brazil
7. 📊 Cochrane Systematic Reviews

References verified on 2026-02-03